Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-21

FDA Approved: ENTECAVIR — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original application for entecavir, a generic antiviral used to treat chronic hepatitis B infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

ORIG AP for ENTECAVIR (ENTECAVIR)